NEW YORK (GenomeWeb News) – Roche said today that its Roche NibleGen subsidiary has inked an alliance with Los Angeles-based BioDiscovery to offer a combination of products targeting comparative genomic hybridization.
The pact will combine new high-density, 2.1 million probe arrays from Roche NimbleGen with BioDiscovery’s Nexus Copy Number software foe use in whole-genome CGH analysis. Under the alliance, the firms will co-market and co-promote their products and services to scientists worldwide.
In addition, Roche NimbleGen said that the firm would present data generated from the arrays using Nexus software to researchers through a series of seminars.
Terms of the alliance were not disclosed.